METABOLIC ASSAY FOR BACTERIAL GROWTH AND GRAM TYPING

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20190300927A1
SERIAL NO

16366244

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The use of metabolic probes is well-established for determining cell viability and assessing drug cytotoxicity. Resazurin-based formulations, in particular, have found utility for determining susceptibilities of microorganisms to antimicrobials, specifically through their use in antibiotic susceptibility testing (AST). There is a strong need currently to shorten AST durations, thus resazurin formulations that produce signals earlier are advantageous. This need results from the slow state of clinical microbiology testing, which may leave patients exposed to unnecessary or ineffective broad-spectrum agents for prolonged periods of time. Another slow microbiology test is Gram staining, still most often performed manually in sequential steps. Speeding Gram typing, preferably with an automated platform, would also speed time-to-results and decrease manual workloads on medical technologists in clinical microbiology laboratories.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SELUX DIAGNOSTICS INCCHARLESTOWN MA 02129

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Flentie, Kelly Charlestown, US 25 37
Spears, Benjamin Charlestown, US 10 17
Stern, Eric Charlestown, US 44 530

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation